These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 29244540)

  • 1. Overcoming Impediments to OTP Expansion in the United States and Abroad.
    Parrino MW
    Subst Use Misuse; 2018 Jan; 53(2):354-355. PubMed ID: 29244540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tailoring services in opioid treatment programs for patients involved in America's criminal justice system: national associations and variation by state and Medicaid expansion status.
    Pro G; Montgomery BEE; Zaller N
    Subst Abuse Treat Prev Policy; 2021 Jun; 16(1):50. PubMed ID: 34147098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicaid Expansion Increased Medications For Opioid Use Disorder Among Adults Referred By Criminal Justice Agencies.
    Khatri UG; Howell BA; Winkelman TNA
    Health Aff (Millwood); 2021 Apr; 40(4):562-570. PubMed ID: 33819101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health Insurance Trends and Access to Behavioral Healthcare Among Justice-Involved Individuals-United States, 2008-2014.
    Winkelman TN; Kieffer EC; Goold SD; Morenoff JD; Cross K; Ayanian JZ
    J Gen Intern Med; 2016 Dec; 31(12):1523-1529. PubMed ID: 27638837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving Access to Substance Abuse Treatment and Reducing Incarceration and Recidivism.
    Brolin M; Dennehy K; Booxbaum A; Horgan C
    Issue Brief (Mass Health Policy Forum); 2015 Nov; (44):1-46. PubMed ID: 27911072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties.
    Stein BD; Pacula RL; Gordon AJ; Burns RM; Leslie DL; Sorbero MJ; Bauhoff S; Mandell TW; Dick AW
    Milbank Q; 2015 Sep; 93(3):561-83. PubMed ID: 26350930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Only One In Twenty Justice-Referred Adults In Specialty Treatment For Opioid Use Receive Methadone Or Buprenorphine.
    Krawczyk N; Picher CE; Feder KA; Saloner B
    Health Aff (Millwood); 2017 Dec; 36(12):2046-2053. PubMed ID: 29200340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Justice-Involved Adults With Substance Use Disorders: Coverage Increased But Rates Of Treatment Did Not In 2014.
    Saloner B; Bandara SN; McGinty EE; Barry CL
    Health Aff (Millwood); 2016 Jun; 35(6):1058-66. PubMed ID: 27269023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing access to medications for opioid use disorder: Policy analysis and proposals.
    Latronica JR
    J Addict Dis; 2021; 39(3):421-424. PubMed ID: 33616013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Policies related to opioid agonist therapy for opioid use disorders: The evolution of state policies from 2004 to 2013.
    Burns RM; Pacula RL; Bauhoff S; Gordon AJ; Hendrikson H; Leslie DL; Stein BD
    Subst Abus; 2016; 37(1):63-9. PubMed ID: 26566761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standards for opioid treatment in the criminal justice system: implications for nurses.
    Chavez RS
    J Addict Nurs; 2012 Feb; 23(1):40-6. PubMed ID: 22468659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Medicaid, Race/Ethnicity, and Criminal Justice Referral on Opioid Use Disorder Treatment.
    Sledge D; Thomas HF; Hoang BL; Mohler G
    J Am Acad Psychiatry Law; 2022 Dec; 50(4):545-551. PubMed ID: 36167412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and treatment patterns of US commercially insured and Medicaid patients with opioid dependence or abuse.
    Wollschlaeger BA; Willson TM; Montejano LB; Ronquest NA; Nadipelli VR
    J Opioid Manag; 2017; 13(4):207-220. PubMed ID: 28953313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey Highlights Differences In Medicaid Coverage For Substance Use Treatment And Opioid Use Disorder Medications.
    Grogan CM; Andrews C; Abraham A; Humphreys K; Pollack HA; Smith BT; Friedmann PD
    Health Aff (Millwood); 2016 Dec; 35(12):2289-2296. PubMed ID: 27920318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV, prisoners, and human rights.
    Rubenstein LS; Amon JJ; McLemore M; Eba P; Dolan K; Lines R; Beyrer C
    Lancet; 2016 Sep; 388(10050):1202-14. PubMed ID: 27427457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vermont responds to its opioid crisis.
    Simpatico TA
    Prev Med; 2015 Nov; 80():10-1. PubMed ID: 25869219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case studies from three states: breaking down silos between health care and criminal justice.
    Bechelli MJ; Caudy M; Gardner TM; Huber A; Mancuso D; Samuels P; Shah T; Venters HD
    Health Aff (Millwood); 2014 Mar; 33(3):474-81. PubMed ID: 24590948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. President's message.
    J Addict Dis; 2021; 39(2):147-151. PubMed ID: 33645458
    [No Abstract]   [Full Text] [Related]  

  • 19. Medication-Assisted Treatment for Opioid Addiction in the United States: Critique and Commentary.
    McElrath K
    Subst Use Misuse; 2018 Jan; 53(2):334-343. PubMed ID: 28862903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future delivery of the Drug Interventions Programme: do the benefits justify the costs?
    Osborne A
    J Forensic Leg Med; 2013 Oct; 20(7):816-20. PubMed ID: 24112327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.